(1) Tsukada, H.; Blow, D. M. Structure of α-Chymotrypsin Refined at 1.68 Å Resolution. J. Mol. Biol.
1985, 184 (4), 703–711. https://doi.org/10.1016/0022-2836(85)90314-6.
(2) Marshall, A.; Keiller, B.; Pederick, J.; Abell, A.; Bruning, J. Crystal Structure of Bovine Alpha-Chymotrypsin in Space Group P65. Crystals 2018, 8 (12), 460.
https://doi.org/10.3390/cryst8120460.
(3) Spillantini, M. G.; Schmidt, M. L.; Lee, V. M. Y.; Trojanowski, J. Q.; Jakes, R.; Goedert, M. α-Synuclein in Lewy Bodies [8]. Nature. Nature Publishing Group 1997, pp 839–840.
https://doi.org/10.1038/42166.
(4) Dauer, W.; Przedborski, S. Parkinson’s Disease: Mechanisms and Models. Neuron. Cell Press September 11, 2003, pp 889–909. https://doi.org/10.1016/S0896-6273(03)00568-3.
(5) Davidson, W. S.; Jonas, A.; Clayton, D. F.; George, J. M. Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic Membranes. J. Biol. Chem. 1998, 273 (16), 9443–9449.
https://doi.org/10.1074/jbc.273.16.9443.
(6) Balupuri, A.; Choi, K. E.; Kang, N. S. Computational Insights into the Role of α-Strand/Sheet in Aggregation of α-Synuclein. Sci. Rep. 2019, 9 (1). https://doi.org/10.1038/s41598-018-37276-1.
(7) Ulmer, T. S.; Bax, A.; Cole, N. B.; Nussbaum, R. L. Structure and Dynamics of Micelle-Bound Human α-Synuclein. J. Biol. Chem. 2005, 280 (10), 9595–9603. https://doi.org/10.1074/jbc.M411805200.
(8) Guerrero-Ferreira, R.; Taylor, N. M. I.; Mona, D.; Ringler, P.; Lauer, M. E.; Riek, R.; Britschgi, M.;
Stahlberg, H. Cryo-EM Structure of Alpha-Synuclein Fibrils. Elife 2018, 7.
https://doi.org/10.7554/eLife.36402.
(9) Ko, T. P.; Day, J.; Malkin, A. J.; McPherson, A. Structure of Orthorhombic Crystals of Beef Liver Catalase. Acta Crystallogr. Sect. D Biol. Crystallogr. 1999, 55 (8), 1383–1394.
31
https://doi.org/10.1107/S0907444999007052.
(10) BRENDA - Information on EC 1.11.1.6 - catalase https://www.brenda-enzymes.org/enzyme.php?ecno=1.11.1.6# (accessed Jul 7, 2020).
(11) Walsh, M. A.; Schneider, T. R.; Sieker, L. C.; Dauter, Z.; Lamzin, V. S.; Wilson, K. S. Refinement of Triclinic Hen Egg-White Lysozyme at Atomic Resolution. Acta Crystallogr. Sect. D Biol. Crystallogr.
1998, 54 (4), 522–546. https://doi.org/10.1107/S0907444997013656.
(12) Ar, V. R. S. Crystallographic Studies of the Activity of Hen Egg-White Lysozyme.
(13) Booth, D. R.; Sundetll, M.; Bellotti, V.; Robinson+, C. V; Hutchinson, W. L.; Fraser, P. E.; Hawkins, P.
N.; Dobson+, C. M.; Radford+~, S. E.; Blaket, C. C. F.; Pepys, M. B. Instability, Unfolding and Aggregation of Human Lysozyme Variants Underlying Amyloid Fibrillogenesis.
(14) Frare, E.; Polverino de Laureto, P.; Zurdo, J.; Dobson, C. M.; Fontana, A. A Highly Amyloidogenic Region of Hen Lysozyme. https://doi.org/10.1016/j.jmb.2004.05.056.
(15) Sivalingam, V.; Prasanna, N. L.; Sharma, N.; Prasad, A.; Patel, B. K. Wild-Type Hen Egg White Lysozyme Aggregation in Vitro Can Form Self-Seeding Amyloid Conformational Variants. 2016.
https://doi.org/10.1016/j.bpc.2016.09.009.
(16) Calvaresi, M.; Arnesano, F.; Bonacchi, S.; Bottoni, A.; Calò, V.; Conte, S.; Falini, G.; Fermani, S.;
Losacco, M.; Montalti, M.; Natile, G.; Prodi, L.; Sparla, F.; Zerbetto, F. C60@Lysozyme: Direct Observation by Nuclear Magnetic Resonance of a 1:1 Fullerene Protein Adduct. ACS Nano 2014, 8 (2), 1871–1877. https://doi.org/10.1021/nn4063374.
(17) Cooper, J. B.; Khan, G.; Taylor, G.; Tickle, I. J.; Blundell, T. L. X-Ray Analyses of Aspartic Proteinases.
II. Three-Dimensional Structure of the Hexagonal Crystal Form of Porcine Pepsin at 2.3A °resolution.
J. Mol. Biol. 1990, 214 (1), 199–222. https://doi.org/10.1016/0022-2836(90)90156-G.
(18) Fujinaga, M.; Chernaia, M. M.; Mosimann, S. C.; James, M. N. G.; Tarasova, N. I. Crystal Structure of Human Pepsin and Its Complex with Pepstatin. Protein Sci. 2008, 4 (5), 960–972.
https://doi.org/10.1002/pro.5560040516.
(19) Sielecki, A. R.; Fedorov, A. A.; Boodhoo, A.; Andreeva, N. S.; James, M. N. G. Molecular and Crystal Structures of Monoclinic Porcine Pepsin Refined at 1.8A °resolution. J. Mol. Biol. 1990, 214 (1), 143–
170. https://doi.org/10.1016/0022-2836(90)90153-D.
(20) FOLTMANN; B. Gastric Proteinases-Structure, Function, Evolution and Mechanism of Action. Essays Biochem. 1981, 17, 52–84.
(21) Dunn, B. M. Structure and Mechanism of the Pepsin-like Family of Aspartic Peptidases. Chem. Rev.
2002, 102 (12), 4431–4458. https://doi.org/10.1021/cr010167q.
(22) Krätschmer, W.; Lamb, L. D.; Fostiropoulos, K.; Huffman, D. R. Solid C60: A New Form of Carbon.
Nature 1990, 347 (6291), 354–358. https://doi.org/10.1038/347354a0.
(23) Kroto, H. W.; Heath, J. R.; O’Brien, S. C.; Curl, R. F.; Smalley, R. E. C60: Buckminsterfullerene. Nature 1985, 318 (6042), 162–163. https://doi.org/10.1038/318162a0.
(24) Lim, C.-S.; Hong, K.; Ko, W. B. Reactions and Properties of Fullerene (C 60 ); 2010; Vol. 45.
(25) Tajima, Y.; Takeshi, K.; Shigemitsu, Y.; Numata, Y. Chemistry of Fullerene Epoxides: Synthesis, Structure, and Nucleophilic Substitution-Addition Reactivity. Molecules 2012, 17 (6), 6395–6414.
https://doi.org/10.3390/molecules17066395.
(26) Nair, V.; Sethumadhavan, D.; Sheela, K. C.; Eigendorf, G. K. Cycloaddition Reactions of Carbonyl Ylides to [60] Fullerene: Synthesis of Novel C60 Derivatives. Tetrahedron Lett. 1999, 40 (27), 5087–
5090. https://doi.org/10.1016/S0040-4039(99)00988-0.
(27) Volpin, M.; … V. R.-M.; 1996, undefined. Aminoacid and Peptid Derivatives of Fullerene-60 and Investigation of Their Properties. … BREACH SCI PUBL LTD C/O STBS ….
32
(28) V.S. Romanova, V. A. T. Y. L. Z. N. P. M. E. V. Addition of Amino Acids and Dipeptides to Fullerene C60 Giving Rise to Monoadducts. Russ. Chem. Bull. 1994, 6, 1090–1091.
(29) Yamskova, O. V.; Kolyagin, Y. G.; Romanova, V. S.; Egorov, A. S.; Kurilov, D. V.; Yamskov, I. A.;
Zubareva, N. D.; Kustov, L. M. Solid-State NMR of C60 Amino Acid Derivatives. Russ. J. Phys. Chem.
A 2019, 93 (2), 308–310. https://doi.org/10.1134/S0036024419020328.
(30) Dugan, L. L.; Turetsky, D. M.; Du, C.; Lobner, D.; Wheeler, M.; Almli, C. R.; Shen, C. K. F.; Luh, T. Y.;
Choi, D. W.; Lin, T. S. Carboxyfullerenes as Neuroprotective Agents. Proc. Natl. Acad. Sci. U. S. A.
1997, 94 (17), 9434–9439. https://doi.org/10.1073/pnas.94.17.9434.
(31) Lin, W.; Insley, T.; Tuttle, M. D.; Zhu, L.; Berthold, D. A.; Král, P.; Rienstra, C. M.; Murphy, C. J. Control of Protein Orientation on Gold Nanoparticles. J. Phys. Chem. C 2015, 119 (36), 21035–21043.
https://doi.org/10.1021/acs.jpcc.5b07701.
(32) Wang, M.; Sun, Y.; Cao, X.; Peng, G.; Javed, I.; Kakinen, A.; Davis, T. P.; Lin, S.; Liu, J.; Ding, F.; Ke, P.
C. Graphene Quantum Dots against Human IAPP Aggregation and Toxicity: In Vivo. Nanoscale 2018, 10 (42), 19995–20006. https://doi.org/10.1039/c8nr07180b.
(33) Alvarez, Y. D.; Fauerbach, J. A.; Pellegrotti, J. V.; Jovin, T. M.; Jares-Erijman, E. A.; Stefani, F. D.
Influence of Gold Nanoparticles on the Kinetics of Alpha-Synuclein Aggregation. Biophys. J. 2014, 106 (2), 257a-258a. https://doi.org/10.1016/j.bpj.2013.11.1513.
(34) Kim, D.; Yoo, J. M.; Hwang, H.; Lee, J.; Lee, S. H.; Yun, S. P.; Park, M. J.; Lee, M. J.; Choi, S.; Kwon, S.
H.; Lee, S.; Kwon, S. H.; Kim, S.; Park, Y. J.; Kinoshita, M.; Lee, Y. H.; Shin, S.; Paik, S. R.; Lee, S. J.; Lee, S.; Hong, B. H.; Ko, H. S. Graphene Quantum Dots Prevent α-Synucleinopathy in Parkinson’s Disease.
Nat. Nanotechnol. 2018, 13 (9), 812–818. https://doi.org/10.1038/s41565-018-0179-y.
(35) Bosi, S.; Da Ros, T.; Spalluto, G.; Prato, M. Fullerene Derivatives: An Attractive Tool for Biological Applications. European Journal of Medicinal Chemistry. Elsevier Masson SAS November 1, 2003, pp 913–923. https://doi.org/10.1016/j.ejmech.2003.09.005.
(36) Vorobyov, V.; Kaptsov, V.; Gordon, R.; Makarova, E.; Podolski, I.; Sengpiel, F. Neuroprotective Effects of Hydrated Fullerene C60: Cortical and Hippocampal EEG Interplay in an Amyloid-Infused Rat Model of Alzheimer’s Disease. J. Alzheimer’s Dis. 2015, 45 (1), 217–233. https://doi.org/10.3233/JAD-142469.
(37) Jin, H.; Chen, W. Q.; Tang, X. W.; Chiang, L. Y.; Yang, C. Y.; Schloss, J. V.; Wu, J. Y. Polyhydroxylated C60, Fullerenols, as Glutamate Receptor Antagonists and Neuroprotective Agents. J. Neurosci. Res.
2000, 62 (4), 600–607. https://doi.org/10.1002/1097-4547(20001115)62:4<600::AID-JNR15>3.0.CO;2-F.
(38) Tong, J.; Zimmerman, M. C.; Li, S.; Yi, X.; Luxenhofer, R.; Jordan, R.; Kabanov, A. V. Neuronal Uptake and Intracellular Superoxide Scavenging of a Fullerene (C 60 )-Poly(2-Oxazoline)s Nanoformulation.
Biomaterials 2011, 32 (14), 3654–3665. https://doi.org/10.1016/j.biomaterials.2011.01.068.
(39) Makarova, E. G.; Gordon, R. Y.; Podolski, I. Y. Fullerene C 60 Prevents Neurotoxicity Induced by Intrahippocampal Microinjection of Amyloid-β Peptide. In Journal of Nanoscience and Nanotechnology; J Nanosci Nanotechnol, 2012; Vol. 12, pp 119–126.
https://doi.org/10.1166/jnn.2012.5709.
(40) Tsao, N.; Luh, T.-Y.; Chou, C.-K.; Chang, T.-Y.; Wu, J.-J.; Liu, C.-C.; Lei, H.-Y. In Vitro Action of Carboxyfullerene. J. Antimicrob. Chemother. 2002, 49 (4), 641–649.
https://doi.org/10.1093/jac/49.4.641.
(41) Tokuyama, H.; Yamago, S.; Nakamura, E.; Shiraki, T.; Sugiura, Y. Photoinduced Biochemical Activity of Fullerene Carboxylic Acid. J. Am. Chem. Soc. 1993, 115 (17), 7918–7919.
https://doi.org/10.1021/ja00070a064.
(42) Ho Park, K.; Chhowalla, M.; Iqbal, Z.; Sesti, F. Single-Walled Carbon Nanotubes Are a New Class of Ion Channel Blockers*. J. Biol. Chem. 2003, 278 (50), 50212–50216.
https://doi.org/10.1074/jbc.M310216200.
33
(43) Wolff, D. J.; Barbieri, C. M.; Richardson, C. F.; Schuster, D. I.; Wilson, S. R. Trisamine C60-Fullerene Adducts Inhibit Neuronal Nitric Oxide Synthase by Acting as Highly Potent Calmodulin Antagonists.
Arch. Biochem. Biophys. 2002, 399 (2), 130–141. https://doi.org/10.1006/abbi.2002.2766.
(44) Mashino, T.; Okuda, K.; Hirota, T.; Hirobe, M.; Nagano, T.; Mochizuki, M. Inhibitory Effect of Fullerene Derivatives on Glutathione Reductase. Fuller. Sci. Technol. 2001, 9 (2), 191–196.
https://doi.org/10.1081/FST-100102966.
(45) Friedman, S. H.; DeCamp, D. L.; Kenyon, G. L.; Sijbesma, R. P.; Srdanov, G.; Wudl, F. Inhibition of the HIV-1 Protease by Fullerene Derivatives: Model Building Studies and Experimental Verification. J.
Am. Chem. Soc. 1993, 115 (15), 6506–6509. https://doi.org/10.1021/ja00068a005.
(46) Luca Marcorin, G.; Da Ros, T.; Castellano, S.; Stefancich, G.; Bonin, I.; Miertus, S.; Prato, M. Design and Synthesis of Novel [60]Fullerene Derivatives as Potential HIV Aspartic Protease Inhibitors. Org.
Lett. 2000, 2 (25), 3955–3957. https://doi.org/10.1021/ol000217y.
(47) Schuster, D. I.; Wilson, S. R.; Schinazi, R. F. Anti-Human Immunodeficiency Virus Activity and Cytotoxicity of Derivatized Buckminsterfullerenes. Bioorganic Med. Chem. Lett. 1996, 6 (11), 1253–
1256. https://doi.org/10.1016/0960-894X(96)00210-7.
(48) Sijbesma, R.; Srdanov, G.; Wudl, F.; Castoro, J. A.; Wilkins, C.; Friedman, S. H.; DeCamp, D. L.; Kenyon, G. L. Synthesis of a Fullerene Derivative for the Inhibition of HIV Enzymes. J. Am. Chem. Soc. 1993, 115 (15), 6510–6512. https://doi.org/10.1021/ja00068a006.
(49) Kim, J. E.; Lee, M. Fullerene Inhibits β-Amyloid Peptide Aggregation. Biochem. Biophys. Res.
Commun. 2003, 303 (2), 576–579. https://doi.org/10.1016/S0006-291X(03)00393-0.
(50) Braden, B. C.; Goldbaum, F. A.; Chen, B. X.; Kirschner, A. N.; Wilson, S. R.; Erlanger, B. F. X-Ray Crystal Structure of an Anti-Buckminsterfullerene Antibody Fab Fragment: Biomolecular Recognition of C60. Proc. Natl. Acad. Sci. U. S. A. 2000, 97 (22), 12193–12197.
https://doi.org/10.1073/pnas.210396197.
(51) Chen, B.-X.; Wilson, S. R.; Das, M.; Coughlin, D. J.; Erlanger, B. F. Antigenicity of Fullerenes: Antibodies Specific for Fullerenes and Their Characteristics; 1998; Vol. 95.
(52) Pastorin, G.; Marchesan, S.; Hoebeke, J.; Da Ros, T.; Ehret-Sabatier, L.; Briand, J. P.; Prato, M.; Bianco, A. Design and Activity of Cationic Fullerene Derivatives as Inhibitors of Acetylcholinesterase. Org.
Biomol. Chem. 2006, 4 (13), 2556–2562. https://doi.org/10.1039/b604361e.
(53) Belgorodsky, B.; Fadeev, L.; Ittah, V.; Benyamini, H.; Zelner, S.; Huppert, D.; Kotlyar, A. B.; Gozin, M.
Formation and Characterization of Stable Human Serum Albumin-Tris-Malonic Acid [C60]Fullerene Complex. Bioconjug. Chem. 2005, 16 (5), 1058–1062. https://doi.org/10.1021/bc050103c.
(54) Rozhkov, S. P.; Goryunov, A. S.; Sukhanova, G. A.; Borisova, A. G.; Rozhkova, N. N.; Andrievsky, G. V.
Protein Interaction with Hydrated C60 Fullerene in Aqueous Solutions. Biochem. Biophys. Res.
Commun. 2003, 303 (2), 562–566. https://doi.org/10.1016/S0006-291X(03)00392-9.
(55) Lakowicz, J. R. Principles of Fluorescence Spectroscopy; Springer, 2006.
https://doi.org/10.1007/978-0-387-46312-4.
(56) Protein Fluorescence. In Principles of Fluorescence Spectroscopy; Springer US, 2006; pp 529–575.
https://doi.org/10.1007/978-0-387-46312-4_16.
(57) Sun, Y. P.; Lawson, G. E.; Huang, W.; Wright, A. D.; Moton, D. K. Preparation and Characterization of Highly Water-Soluble Pendant Fullerene Polymers. Macromolecules 1999, 32 (26), 8747–8752.
https://doi.org/10.1021/ma9906736.
(58) Prabha, C. R.; Patel, R.; Murthy, C. N. Studies on Protein - [60]Fullerene Interactions: The Lysozyme - [60]Fullerene Model System. Fullerenes Nanotub. Carbon Nanostructures 2004, 12 (1–2), 405–412.
https://doi.org/10.1081/FST-120027199.
(59) Di Giosia, M.; Bomans, P. H. H.; Bottoni, A.; Cantelli, A.; Falini, G.; Franchi, P.; Guarracino, G.;
Friedrich, H.; Lucarini, M.; Paolucci, F.; Rapino, S.; Sommerdijk, N. A. J. M.; Soldà, A.; Valle, F.;
34
Zerbetto, F.; Calvaresi, M. Proteins as Supramolecular Hosts for C60: A True Solution of C60 in Water.
Nanoscale 2018, 10 (21), 9908–9916. https://doi.org/10.1039/c8nr02220h.
(60) Giełdoń, A.; Witt, M. M.; Gajewicz, A.; Puzyn, T. Rapid Insight into C60 Influence on Biological Functions of Proteins. Struct. Chem. 2017, 28 (6), 1775–1788. https://doi.org/10.1007/s11224-017-0957-4.
(61) Benyamini, H.; Shulman-Peleg, A.; Wolfson, H. J.; Belgorodsky, B.; Fadeev, L.; Gozin, M. Interaction of C60-Fullerene and Carboxyfullerene with Proteins: Docking and Binding Site Alignment.
Bioconjug. Chem. 2006, 17 (2), 378–386. https://doi.org/10.1021/bc050299g.
(62) Soldà, A.; Cantelli, A.; Di Giosia, M.; Montalti, M.; Zerbetto, F.; Rapino, S.; Calvaresi, M.
C60@lysozyme: A New Photosensitizing Agent for Photodynamic Therapy. J. Mater. Chem. B 2017, 5 (32), 6608–6615. https://doi.org/10.1039/c7tb00800g.
(63) Pradhan, S.; Rajamani, S.; Agrawal, G.; Dash, M.; Samal, S. K. NMR, FT-IR and Raman Characterization of Biomaterials. In Characterization of Polymeric Biomaterials; Elsevier, 2017; pp 147–173.
https://doi.org/10.1016/B978-0-08-100737-2.00007-8.
(64) Chirayil, C. J.; Abraham, J.; Mishra, R. K.; George, S. C.; Thomas, S. Instrumental Techniques for the Characterization of Nanoparticles. In Thermal and Rheological Measurement Techniques for Nanomaterials Characterization; Elsevier, 2017; Vol. 3, pp 1–36. https://doi.org/10.1016/B978-0-323-46139-9.00001-3.
(65) Szakács, Z.; Sánta, Z. NMR Methodological Overview. In Anthropic Awareness: The Human Aspects of Scientific Thinking in NMR Spectroscopy and Mass Spectrometry; Elsevier Inc., 2015; pp 257–289.
https://doi.org/10.1016/B978-0-12-419963-7.00007-9.
(66) Sinha Ray, S. Structure and Morphology Characterization Techniques. In Clay-Containing Polymer Nanocomposites; Elsevier, 2013; pp 39–66. https://doi.org/10.1016/b978-0-444-59437-2.00003-x.
(67) Zeng, C.; Vitale-Sullivan, C.; Ma, X. In Situ Atomic Force Microscopy Studies on Nucleation and Self-Assembly of Biogenic and Bio-Inspired Materials. Minerals. MDPI AG September 1, 2017, p 158.
https://doi.org/10.3390/min7090158.
(68) Khurana, R.; Coleman, C.; Ionescu-Zanetti, C.; Carter, S. A.; Krishna, V.; Grover, R. K.; Roy, R.; Singh, S. Mechanism of Thioflavin T Binding to Amyloid Fibrils. J. Struct. Biol. 2005, 151 (3), 229–238.
https://doi.org/10.1016/j.jsb.2005.06.006.
(69) Woods, A. S.; Ferré, S. Amazing Stability of the Arginine-Phosphate Electrostatic Interaction. J.
Proteome Res. 2005, 4 (4), 1397–1402. https://doi.org/10.1021/pr050077s.
(70) Woods, A. S. The Mighty Arginine, the Stable Quaternary Amines, the Powerful Aromatics, and the Aggressive Phosphate: Their Role in the Noncovalent Minuet. J. Proteome Res. 2004, 3 (3), 478–484.
https://doi.org/10.1021/pr034091l.
(71) Kotelnikova, R. A.; Bogdanov, G. N.; Frog, E. C.; Kotelnikov, A. I.; Shtolko, V. N.; Romanova, V. S.;
Andreev, S. M.; Kushch, A. A.; Fedorova, N. E.; Medzhidova, A. A.; Miller, G. G. Nanobionics of Pharmacologically Active Derivatives of Fullerene C 60. J. Nanoparticle Res. 2003, 5 (5–6), 561–566.
https://doi.org/10.1023/B:NANO.0000006070.61144.93.
(72) R.A. Kotelnikova, A. I. K. G. N. B. V. S. R. E. F. K. Z. N. P. M. E. V. Membranotropic Properties of Water Soluble Amino Acid and Peptide Derivatives of Fullerene C60. FEBS Lett. 1996, 389, 111–114.
(73) Andreev, I.; Petrukhina, A.; Garmanova, A.; Babakhin, A.; Andreev, S.; Romanova, V.; Troshin, P.;
Troshina, O.; DuBuske, L. Penetration of Fullerene C60 Derivatives through Biological Membranes.
Fullerenes Nanotub. Carbon Nanostructures 2008, 16 (2), 89–102.
https://doi.org/10.1080/15363830701885831.
(74) Almeida, P. Proteins: Concepts in Biochemistry; Almeida, P., Ed.; Garland Science: New York, 2016.